Author:
Ruamviboonsuk Paisan,Chotcomwonse Peranut,Nganthavee Variya,Pattanapongpaiboon Warissara,Hemarat Kornwipa
Reference84 articles.
1. Özkiris A. Anti-VEGF agents for age-related macular degeneration. Expert Opin Ther Pat. 2010;20(1):103–18.
2. Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2019;3:1–123.
3. Guo MY, Cheng J, Etminan M, Zafari Z, Maberley D. One year effectiveness study of intravitreal aflibercept in neovascular age-related macular degeneration: a meta-analysis. Acta Ophthalmol. 2019;97(1):e1–7.
4. Li J, Xu J, Chen Y, Zhang J, Cao Y, Lu P. Efficacy comparison of intravitreal anti-VEGF therapy for three subtypes of neovascular age-related macular degeneration: a systematic review and meta-analysis. J Ophthalmol. 2018;2018:1–10.
5. Kovach JL, Schwartz SG, Flynn HW, Scott IU. Anti-VEGF treatment strategies for wet AMD. J Ophthalmol. 2012;2012:1–7.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献